Breast cancer therapy in China: Introducing the Special Collection von Wang, Xiaojia, O’Regan, Ruth M.

Volltext

Targeting forkhead box M1 transcription factor in breast cancer von O'Regan, Ruth M., Nahta, Rita

Volltext

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all? von Dhakal, Ajay, Falkson, Carla, O’Regan, Ruth M.

Volltext

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies von Sharifi, Marina N., Anandan, Apoorva, Grogan, Patrick, O’Regan, Ruth M.

Volltext

When the personal becomes political: The impact of the Dobbs decision on women with cancer von Meisel, Jane Lowe, Harrington, Amy, Whaley, Natalie, Vitek, Wendy, O’Regan, Ruth M.

Volltext

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers von Nahta, Rita, O’Regan, Ruth M.

Volltext

Social media and clinical trials: The pros and cons gain context when the patient is at the center von Thompson, Michael A., O’Regan, Ruth M.

Volltext

Progress in breast cancer research amid the COVID‐19 gloom von Khuri, Fadlo R., O’Regan, Ruth M.

Volltext

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer? von Kalinsky, Kevin, O’Regan, Ruth M.

Volltext

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer von Liu, Deli, Xiong, Huan, Ellis, Angela E, Northrup, Nicole C, Rodriguez, Jr, Carlos O, O'Regan, Ruth M, Dalton, Stephen, Zhao, Shaying

Volltext

Emerging use of nanoparticles in diagnosis and treatment of breast cancer von Yezhelyev, Maksym V, Gao, Xiaohu, Xing, Yun, Al-Hajj, Ahmad, Nie, Shuming, O'Regan, Ruth M

Volltext

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer von Hu, Yang, Manasrah, Baraa K, McGregor, Stephanie M, Lera, Robert F, Norman, Roshan X, Tucker, John B, Scribano, Christina M, Yan, Rachel E, Humayun, Mouhita, Wisinski, Kari B, Tevaarwerk, Amye J, O'Regan, Ruth M, Wilke, Lee G, Weaver, Beth A, Beebe, David J, Jin, Ning, Burkard, Mark E

Volltext

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth fac... von Saxena, Neeraj K, Taliaferro-Smith, LaTonia, Knight, Brandi B, Merlin, Didier, Anania, Frank A, O'Regan, Ruth M, Sharma, Dipali

Volltext

Creating the High School Pipeline for Future Deaf Scientists in Academic Medicine von Hall, Wyatte C, O'Dell, Nicole, Gordon, Sarah, Ogden, Susan, McLetchie, Antony A L, O'Regan, Ruth M

Volltext

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer von El Ayachi, Ikbale, Fatima, Iram, Wend, Peter, Alva-Ornelas, Jackelyn A, Runke, Stephanie, Kuenzinger, William L, Silva, Julio, Silva, Wendy, Gray, Joseph K, Lehr, Stephan, Barch, Hilaire C, Krutilina, Raisa I, White, Andrew C, Cardiff, Robert, Yee, Lisa D, Yang, Lily, O'Regan, Ruth M, Lowry, William E, Seagroves, Tiffany N, Seewaldt, Victoria, Krum, Susan A, Miranda-Carboni, Gustavo A

Volltext

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells von Graham, Tisheeka R, Zhau, Haiyen E, Odero-Marah, Valerie A, Osunkoya, Adeboye O, Kimbro, K Sean, Tighiouart, Mourad, Liu, Tongrui, Simons, Jonathan W, O'Regan, Ruth M

Volltext

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach? von Paplomata, Elisavet, Nahta, Rita, O'Regan, Ruth M.

Volltext

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells von Liu, Tongrui, Yacoub, Rami, Taliaferro-Smith, LaTonia D, Sun, Shi-Yong, Graham, Tisheeka R, Dolan, Ryan, Lobo, Christine, Tighiouart, Mourad, Yang, Lily, Adams, Amy, O'Regan, Ruth M

Volltext

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxa... von Hurvitz, Sara A., Dalenc, Florence, Campone, Mario, O’Regan, Ruth M., Tjan-Heijnen, Vivianne C., Gligorov, Joseph, Llombart, Antonio, Jhangiani, Haresh, Mirshahidi, Hamid R., Tan-Chiu, Elizabeth, Miao, Sara, El-Hashimy, Mona, Lincy, Jeremie, Taran, Tetiana, Soria, Jean-Charles, Sahmoud, Tarek, André, Fabrice

Volltext

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition von Hicks, David, O'Regan, Ruth M

Volltext